financetom
Business
financetom
/
Business
/
Four Corners Property Trust Q3 rental revenue rises
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Four Corners Property Trust Q3 rental revenue rises
Oct 28, 2025 2:11 PM

Overview

* FCPT Q3 rental revenue grows 12.2% yr/yr to $66.5 mln

* Net income for Q3 rises to $28.8 mln, reflecting portfolio growth

* Company acquired $82 mln in properties, enhancing portfolio

Outlook

* Company highlights significant liquidity and low leverage profile for future growth

Result Drivers

* PROPERTY ACQUISITIONS - FCPT acquired $82 mln in properties, diversifying across core retail sectors, contributing to portfolio growth

* RENT COLLECTION - Co received 99.9% of its portfolio contractual base rent for Q3, indicating strong rent collection

* LOW LEVERAGE - FCPT maintains one of the lowest leverage profiles in its history, supporting future growth

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 $66.5

Rental mln

Revenue

Q3 EPS $0.28

Q3 Net $28.87

Income mln

Q3 $0.35

Dividend

Q3 $32.47

Operatin mln

g

Expenses

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the commercial reits peer group is "buy."

* Wall Street's median 12-month price target for Four Corners Property Trust Inc ( FCPT ) is $29.00, about 16.1% above its October 27 closing price of $24.34

* The stock recently traded at 21 times the next 12-month earnings vs. a P/E of 24 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Aramco to buy 10% stake in Renault, Geely thermal engines JV
Aramco to buy 10% stake in Renault, Geely thermal engines JV
Jun 28, 2024
(Reuters) -Saudi Aramco will take a 10% stake in Horse Powertrain, the thermal engines joint venture between Renault and Geely, the Chinese automaker said on Friday. Reuters earlier in the day reported that Aramco was close to buying a 10% stake in Horse Powertrain. The transaction values the joint venture, which supplies gasoline engines, hybrid systems and gearboxes for thermal...
Alcoa Announces Launch of Industrial-Scale Elysis Technology
Alcoa Announces Launch of Industrial-Scale Elysis Technology
Jun 28, 2024
11:04 AM EDT, 06/28/2024 (MT Newswires) -- Alcoa ( AA ) said Friday that Rio Tinto plans to launch the first industrial-scale demonstration of Elysis technology, which eliminates all greenhouse gas emissions from traditional smelting process and produces oxygen. Elysis was formed as a partnership between Alcoa ( AA ) and Rio Tinto in 2018, according to Alcoa ( AA...
HireRight Says Acquisition by General Atlantic, Stone Point Capital Completed
HireRight Says Acquisition by General Atlantic, Stone Point Capital Completed
Jun 28, 2024
11:02 AM EDT, 06/28/2024 (MT Newswires) -- HireRight Holdings ( HRT ) said Friday that its acquisition by investment funds affiliated with General Atlantic and Stone Point Capital in a $1.7 billion deal has been completed. Under the terms of the agreement, General Atlantic and Stone Point acquired the shares they did not already own in HireRight ( HRT )...
Atossa Therapeutics Doubles Z-Endoxifen Dose in Phase 2 Breast Cancer Study
Atossa Therapeutics Doubles Z-Endoxifen Dose in Phase 2 Breast Cancer Study
Jun 28, 2024
11:02 AM EDT, 06/28/2024 (MT Newswires) -- Atossa Therapeutics ( ATOS ) said Friday it increased the dose of [Z]-endoxifen to 80 milligrams daily from 40 mg in its phase 2 study of [Z]-endoxifen combined with Eli Lilly's ( LLY ) abemaciclib in patients with newly diagnosed estrogen receptor positive / human epidermal growth factor receptor 2 negative breast cancer....
Copyright 2023-2026 - www.financetom.com All Rights Reserved